CGEM
USDCullinan Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$7.800
High
$7.800
Low
$7.360
Volume
0.61M
Company Fundamentals
Market Cap
437.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.89M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
Related Stocks
NVR
NVR Inc.
GRX
The Gabelli Healthcare & Wellness Trust Common Shares of Beneficial Interest
HASI
HA Sustainable Infrastructure Capital Inc.
WWR
Westwater Resources Inc.
NAD
Nuveen Quality Municipal Income Fund
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.